Skip to main content
TipRanks
Go Ultimate75% OFF

SinoMab Bioscience Ltd. (3681) Financial Statements

1 Followers

SinoMab Bioscience Ltd. Financial Overview

SinoMab Bioscience Ltd.'s market cap is currently ¥1.37B. The company's EPS TTM is ¥-0.13; its P/E ratio is -6.38; SinoMab Bioscience Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 0.00¥ 2.03M¥ 1.36M¥ 4.03M¥ 26.66M
Gross Profit¥ -26.64M¥ 543.00K¥ 422.00K¥ 4.03M¥ 26.66M
Operating Income¥ -124.70M¥ -161.35M¥ -229.57M¥ -258.93M¥ -305.86M
EBITDA¥ -72.11M¥ -132.89M¥ -200.46M¥ -230.89M¥ -285.20M
Net Income¥ -102.27M¥ -185.14M¥ -243.11M¥ -284.16M¥ -288.19M
Balance Sheet
Cash & Short-Term Investments¥ 382.40M¥ 106.88M¥ 234.66M¥ 376.19M¥ 589.53M
Total Assets¥ 908.50M¥ 753.10M¥ 847.79M¥ 1.01B¥ 1.04B
Total Debt¥ 338.64M¥ 482.27M¥ 450.81M¥ 357.18M¥ 275.46M
Net Debt¥ 4.97M¥ 420.37M¥ 247.14M¥ 11.47M¥ -287.52M
Total Liabilities¥ 400.41M¥ 560.19M¥ 552.20M¥ 498.77M¥ 361.43M
Stockholders' Equity¥ 508.10M¥ 192.91M¥ 295.58M¥ 509.57M¥ 680.23M
Cash Flow
Free Cash Flow¥ -95.78M¥ -172.30M¥ -237.74M¥ -413.29M¥ -345.30M
Operating Cash Flow¥ -70.48M¥ -130.80M¥ -133.85M¥ -300.54M¥ -147.06M
Investing Cash Flow¥ 16.25M¥ -94.48M¥ -96.92M¥ -81.36M¥ -137.70M
Financing Cash Flow¥ 329.39M¥ 73.27M¥ 82.27M¥ 102.28M¥ 57.52M

Currency in CNY

SinoMab Bioscience Ltd. Earnings and Revenue History

-400M-200M0200M-24000 %-16000 %-8000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

SinoMab Bioscience Ltd. Liabilities to Assets

0500M1B1.5B0 %50 %100 %150 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

SinoMab Bioscience Ltd. Cash Flow

-500M0500M1B1.5B2B201720182019202020212022202320242025OperatingInvestingFinancing

SinoMab Bioscience Ltd. Forecast EPS vs Actual EPS

-0.1-0.1-0.1-0.100Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss